Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Investigate Signaling Pathways in Placentas of Overweight or Obese Patients and Patients With Gestational Diabetes Mellitus

NCT05424965 is registered in ClinicalTrials.gov with Sarah Appel as lead sponsor.

NCT NCT05424965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05424965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Investigate Signaling Pathways in Placentas of Overweight or Obese Patients and Patients With Gestational Diabetes Mellitus
Lead sponsor
Sarah Appel
Phase
Observational
Overall status
Unknown status
Start date
March 23, 2018
Completion date
December 31, 2022
Enrollment
247 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gestational diabetes mellitus in pregnancy, obesity, maternal